Heartline™ - Transtelephonic ECG System
Navigation Links
Heartline™ - Transtelephonic ECG System
| Products | Heartline™ - Transtelephonic ECG System |
| Company | Aerotel Medical Systems Ltd. |
| Item | Heartline™ - Transtelephonic ECG System |
| Features | The Heartline™ System
|
| Description | Aerotels Heartline™ system is winning the hearts of cardiologists and cardiac patients around the world. "Remaining calm are the operative words for Heartline™. Patients conduct normal, mobile lives. At the same time they and their attending physician know that a professional response to any change in their heart condition is only a phone call away. Heartline™ is designed for various diagnostic, emergency and monitoring service applications, it comprises a complete range of personal, 1-12 lead Transtelephonic devices for variable remote diagnostic and emergency service applications. The recorded ECG signals are transmitted through the telephone to a medical center, where a PC-based ECG receiving station receives the transmitted ECG and displays it. |
| Info | Aerotel Medical Systems Ltd. Customer Service: 972-3-559-3222 |
Related medicine products :
1. Heart 2005A Transtelephonic ECG Loop Event Recorder
2. Heart 2006™ Dual Lead Transtelephonic ECG Loop Event Recorder
3. BP-Tel™ Transtelephonic BP Monitor
4. Silicone Oil Cannula System - 20 Gauge
5. Silicone Oil Cannula System - 19 Gauge
6. SuperVu Galilean System
7. KOWA nonmyd 7 / VK-2 Digital Imaging System
8. KOWA nonmyd a-D / VK-2 Digital Imaging System
9. Refraction System RT-2100
10. Odyssey Phacoemulsification System
11. SIStem Phacoemulsification System
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
Medicine Products:(Date:7/8/2008)... , Cincinnati, OH, July 7, 2008Girls moving throu...weight gain, but the reasons for this are not alwa...t gain are easily overlooked. A new study soon to...zes the effect of Internet usage, sleep, and alcoh...cent girls. , Dr. Catherine Berkey and colleag...
(Date:7/8/2008)... Elvia Barboa, Chief Executive Officer of PADRES...pelling rumors their National Spokesperson Fernand...reatment, LOS ANGELES, July 8 /PRNewswire/ -- In ...n,s Fernando Del Rincon,s cancer diagnosis was,fab...f, PADRES CEO, Elvia,Barboa, M.A., found it impera...
(Date:7/8/2008)... , Alexandria, Va.A study conducted in Sweden fou...ountry whose wives died from cancer four or five y...that their spouse,s cancer was incurable, or they ... life. Eighty-six percent of widowers believed nex...cancer is incurable, including 71 percent of the m...
(Date:7/8/2008)... , SKINTASTIC™ is...oved Evolence®--the latest injectable collagen...-downtime beauty treatments. EVOLENCE® utilize...d as a preferred medical grafting substance due to.... , N. Dallas/Plano, TX (...
Breaking Medicine News(10 mins):Health News:The Internet, alcohol and sleep 2Health News:Rumors Dispelled Over Univision Talent Fernando Del Rincon's Cancer Diagnosis Being Fabricated 2Health News:Study finds that significant proportion of men told wife's cancer was incurable late or not at all 2Health News:Move Over, Popular Beauty Fillers--Here Comes Evolence 2Health News:Move Over, Popular Beauty Fillers--Here Comes Evolence 3...th Ministers of Southern States will be held here ...ing chikungunya,Karnataka Health Minister R Ashok ...of submitting a memorandum to the Centre seeking f...f medicines, he told reporters here. The Karnataka...
...igures of pregnancy-related deaths and to reduce m...s decided to conduct a detailed audit to find out/...ortality ratio (MMR) in Rajasthan is 677. MMR is t...rths and is a measure of the death of risk once a ...
... the rescued five-year-old boy Prince, who was tra...eclared that the child was safe and did not// suff...ed boy was being brought to state capital Chandiga...e super-specialty Post-Graduate Institute of Medic...
...n anti-smoking lessons in the classroom to keep sc...rding to a recent review of studies.// There is li...e effective in the long term in preventing kids fr...homas, lead reviewer and a professor in the family...
Other Medicine News:Health News:Rajasthan to Conduct Audit to Find Out the Cause of Maternal Mortality 2Health News:Students Light Up Despite School Anti-Smoking Programs 2Health News:Students Light Up Despite School Anti-Smoking Programs 3(Date:7/7/2008)...e/ -- OrbusNeich today announced that data,present...nese Society of,Interventional Cardiology demonstr...ter outcomes when compared to drug-eluting stents....,s principal,investigator and a professor with the...rdiology, Department of Clinical Medicine and Card...
(Date:7/7/2008)...fruit is Top Performer in the Body, SEATTLE, July...l when,it comes to their antioxidant powers in the...bility compared to other antioxidant-rich fruits a... in the Journal of the,American College of Nutriti...cals called flavonoids that,may have the power to ...
(Date:7/3/2008)...swire-FirstCall/ -- Medivation, Inc.,(Nasdaq: MDV...ence at 5:00,p.m. EDT on Monday, July 7, to discus...nd, placebo-controlled Phase 2 clinical trial of,d...ce/Webcast Details, To participate in the live ca... telephone, please dial 877-419-6590 from the U.S....
(Date:7/3/2008)...BRIDGE Massachusetts, July 3,/PRNewswire-FirstCall...logy company, Jerini AG for an equity purchase pr... (HAE) product, FIRAZYR(R), to its Human Genetic ...global sales expected to be around $350-400 milli...e environment, - Expected to be accretive for Non...
Breaking Medicine Technology:Data Presented at Annual Meeting of Japanese Society of Interventional Cardiology Demonstrate OrbusNeich's Genous(TM) Bio-engineered R Stent(TM) Has Better Outcomes When Compared to Drug-Eluting Stents 2Data Presented at Annual Meeting of Japanese Society of Interventional Cardiology Demonstrate OrbusNeich's Genous(TM) Bio-engineered R Stent(TM) Has Better Outcomes When Compared to Drug-Eluting Stents 3Kiwifruit: Antioxidant Power in Quantity and Quality 2Medivation to Host Conference Call at 5 p.m. EDT Monday to Discuss Top-Line Phase 2 Study Results in Huntington's Disease 2Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 2Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 3Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 4Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 5Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 6Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 7Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 8Complementary Excerpt Available from Best Practices 3A Resources Structure and Processes to Optimize Pharmaceutical Sales Communications 17241 1Complementary Excerpt Available from Best Practices 3A Resources Structure and Processes to Optimize Pharmaceutical Sales Communications 17241 2Gene Therapy in Rats Reduces Cocaine Use 17237 1Gene Therapy in Rats Reduces Cocaine Use 17237 2Dealing Cervical Cancer a Knockout Blow 17234 1Dealing Cervical Cancer a Knockout Blow 17234 2Dealing Cervical Cancer a Knockout Blow 17234 3Best Practice Database 3A Valuable Strategies for Pharmaceutical Product Launches 17230 1Best Practice Database 3A Valuable Strategies for Pharmaceutical Product Launches 17230 2[0] Data Presented at Annual Meeting of Japanese Society of Interventional Cardiology Demonstrate OrbusNeich's Genous(TM) Bio-engineered R Stent(TM) Has Better Outcomes When Compared to Drug-Eluting Stents[0] Kiwifruit: Antioxidant Power in Quantity and Quality[1] Medivation to Host Conference Call at 5 p.m. EDT Monday to Discuss Top-Line Phase 2 Study Results in Huntington's Disease[0] Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent
...HICAGO, June 21, 2007 /PRNewswire-FirstCall/ -- Ad...ced positive results from,Trial CL-06, the first o...assess the safety and effectiveness of cethromycin... of community,acquired pneumonia (CAP). In the stu...imary endpoint of per protocol clinical,cure rate ...
...ummary: Pharmexa-Epimmune, the U.S.-based subsidia...s influenza vaccine,program today at the Influenza...Influenza VI," held in Toronto, Ontario, Canada. T...o induce,cell-mediated immune responses can protec...uenza virus challenge. , HORSOLM, Denmark, June 21...
Other Medicine Technology:Cethromycin Achieves Primary Endpoint in Pivotal Phase 3 Pneumonia,Clinical Trial 2Cethromycin Achieves Primary Endpoint in Pivotal Phase 3 Pneumonia,Clinical Trial 3Cethromycin Achieves Primary Endpoint in Pivotal Phase 3 Pneumonia,Clinical Trial 4Cethromycin Achieves Primary Endpoint in Pivotal Phase 3 Pneumonia,Clinical Trial 5Pharmexa A/S (DK) - Pharmexa presents data from influenza program 2| Copyright © 2003-2008 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |